299 related articles for article (PubMed ID: 34225614)
1. Novel Drug Delivery System for Curcumin: Implementation to Improve Therapeutic Efficacy against Neurological Disorders.
Mohi-Ud-Din R; Mir RH; Wani TU; Shah AJ; Mohi-Ud-Din I; Dar MA; Pottoo FH
Comb Chem High Throughput Screen; 2022; 25(4):607-615. PubMed ID: 34225614
[TBL] [Abstract][Full Text] [Related]
2. Benefits of curcumin in brain disorders.
Bhat A; Mahalakshmi AM; Ray B; Tuladhar S; Hediyal TA; Manthiannem E; Padamati J; Chandra R; Chidambaram SB; Sakharkar MK
Biofactors; 2019 Sep; 45(5):666-689. PubMed ID: 31185140
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders.
Yavarpour-Bali H; Ghasemi-Kasman M; Pirzadeh M
Int J Nanomedicine; 2019; 14():4449-4460. PubMed ID: 31417253
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of Curcumin in Neurodegenerative Diseases.
Genchi G; Lauria G; Catalano A; Carocci A; Sinicropi MS
Foods; 2024 Jun; 13(11):. PubMed ID: 38891002
[TBL] [Abstract][Full Text] [Related]
5. Role of curcumin and its nanoformulations in neurotherapeutics: A comprehensive review.
Mandal M; Jaiswal P; Mishra A
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22478. PubMed ID: 32124518
[TBL] [Abstract][Full Text] [Related]
6. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability of curcumin: problems and advancements.
Liu W; Zhai Y; Heng X; Che FY; Chen W; Sun D; Zhai G
J Drug Target; 2016 Sep; 24(8):694-702. PubMed ID: 26942997
[TBL] [Abstract][Full Text] [Related]
8. Recent updates in curcumin delivery.
Obeid MA; Alsaadi M; Aljabali AA
J Liposome Res; 2023 Mar; 33(1):53-64. PubMed ID: 35699160
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by curcumin: A review on brain delivery strategies.
Askarizadeh A; Barreto GE; Henney NC; Majeed M; Sahebkar A
Int J Pharm; 2020 Jul; 585():119476. PubMed ID: 32473377
[TBL] [Abstract][Full Text] [Related]
10. Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.
Godse S; Zhou L; Sakshi S; Singla B; Singh UP; Kumar S
Exp Biol Med (Maywood); 2023 Nov; 248(22):2151-2166. PubMed ID: 38058006
[TBL] [Abstract][Full Text] [Related]
11. Conundrum and therapeutic potential of curcumin in drug delivery.
Kumar A; Ahuja A; Ali J; Baboota S
Crit Rev Ther Drug Carrier Syst; 2010; 27(4):279-312. PubMed ID: 20932240
[TBL] [Abstract][Full Text] [Related]
12. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development.
Grabska-Kobyłecka I; Szpakowski P; Król A; Książek-Winiarek D; Kobyłecki A; Głąbiński A; Nowak D
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571391
[TBL] [Abstract][Full Text] [Related]
13. Curcumin nanoformulations: a future nanomedicine for cancer.
Yallapu MM; Jaggi M; Chauhan SC
Drug Discov Today; 2012 Jan; 17(1-2):71-80. PubMed ID: 21959306
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-applied curcumin for different diseases therapy.
Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
[TBL] [Abstract][Full Text] [Related]
15. Curcumin nanoformulations: Beneficial nanomedicine against cancer.
Maleki Dizaj S; Alipour M; Dalir Abdolahinia E; Ahmadian E; Eftekhari A; Forouhandeh H; Rahbar Saadat Y; Sharifi S; Zununi Vahed S
Phytother Res; 2022 Mar; 36(3):1156-1181. PubMed ID: 35129230
[TBL] [Abstract][Full Text] [Related]
16. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview.
D'Angelo NA; Noronha MA; Kurnik IS; Câmara MCC; Vieira JM; Abrunhosa L; Martins JT; Alves TFR; Tundisi LL; Ataide JA; Costa JSR; Jozala AF; Nascimento LO; Mazzola PG; Chaud MV; Vicente AA; Lopes AM
Int J Pharm; 2021 Jul; 604():120534. PubMed ID: 33781887
[TBL] [Abstract][Full Text] [Related]
17. Advances in nanotechnology-based delivery systems for curcumin.
Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
[TBL] [Abstract][Full Text] [Related]
18. Effects of curcumin on neurological diseases: focus on astrocytes.
Eghbaliferiz S; Farhadi F; Barreto GE; Majeed M; Sahebkar A
Pharmacol Rep; 2020 Aug; 72(4):769-782. PubMed ID: 32458309
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in colloidal delivery systems for nutraceuticals: A case study - Delivery by Design of curcumin.
Kharat M; McClements DJ
J Colloid Interface Sci; 2019 Dec; 557():506-518. PubMed ID: 31542691
[TBL] [Abstract][Full Text] [Related]
20. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of NMRI mice - Impact on bioavailability.
Hagl S; Kocher A; Schiborr C; Kolesova N; Frank J; Eckert GP
Neurochem Int; 2015 Oct; 89():234-42. PubMed ID: 26254982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
